Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Apollo Therapeutics Ltd
First Affiliated Hospital of Zhejiang University
Cullgen (Shanghai),Inc
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology